Mind Medicine MindMed (MNMD)
(Real Time Quote from BATS)
$7.50 USD
+0.03 (0.40%)
Updated Jul 12, 2024 10:20 AM ET
3-Hold of 5 3
D Value C Growth A Momentum D VGM
Balance Sheet
Fiscal Year End for Mind Medicine MindMed Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 100 | 142 | 134 | 80 | 0 |
Receivables | 0 | 0 | 0 | 0 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 4 | 4 | 1 | 0 |
Total Current Assets | 104 | 146 | 137 | 82 | 0 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 20 | 24 | 27 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 125 | 170 | 164 | 82 | 0 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 4 | 2 | 4 | 2 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 12 | 6 | 6 | 1 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 16 | 10 | 0 | 0 | 0 |
Total Current Liabilities | 32 | 18 | 10 | 3 | 0 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 14 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 2 | 3 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 46 | 19 | 12 | 6 | 0 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 368 | 345 | 288 | 120 | 0 |
Retained Earnings | -290 | -194 | -138 | -45 | 0 |
Other Equity | 0 | 1 | 1 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 78 | 151 | 152 | 76 | 0 |
Total Liabilities & Shareholder's Equity | 125 | 170 | 164 | 82 | 0 |
Total Common Equity | 78 | 151 | 152 | 76 | 0 |
Shares Outstanding | 41.10 | 37.90 | 28.10 | 20.40 | NA |
Book Value Per Share | 1.90 | 3.98 | 5.40 | 3.72 | 0.00 |
Fiscal Year End for Mind Medicine MindMed Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 252 | 100 | 118 | 117 |
Receivables | NA | 0 | 0 | 0 | 0 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 3 | 4 | 2 | 3 |
Total Current Assets | NA | 255 | 104 | 120 | 120 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 20 | 20 | 21 | 22 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 276 | 125 | 142 | 142 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 8 | 4 | 8 | 9 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 10 | 12 | 10 | 10 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 48 | 16 | 14 | 17 |
Total Current Liabilities | NA | 65 | 32 | 31 | 35 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 14 | 14 | 14 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 1 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 79 | 46 | 46 | 36 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 540 | 368 | 362 | 354 |
Retained Earnings | NA | -345 | -290 | -266 | -248 |
Other Equity | NA | 1 | 0 | 1 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 196 | 78 | 96 | 106 |
Total Liabilities & Shareholder's Equity | NA | 276 | 125 | 142 | 142 |
Total Common Equity | 0 | 196 | 78 | 96 | 106 |
Shares Outstanding | 71.80 | 71.80 | 41.10 | 40.10 | 39.70 |
Book Value Per Share | 0.00 | 2.73 | 1.90 | 2.39 | 2.67 |